The Patent Finder

Actinium Pharmaceuticals, Inc.

32 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

6
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Stabilized Radiolabeled ANTI-CD45 Immunoglobulin Compositions (US 10,420,851) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due May 7, 2027
    The maintenance fee for Steering Device and Steering Unit Device (US 11,807,314) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
  • 1 fee due Jun 19, 2027
    The maintenance fee for Method for Treating Cancer Using a BCL-2 Inhibitor in Conjunction with an Alpha-Emitting Radioimmunotherapeutic (US 11,844,799) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies (US 11,912,780) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Bifunctional Chelators and Conjugates (US 11,964,948) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
  • 2 fees due Nov 7 to 14, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,349,391Radium target and method for producing it
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,790,573Method for Purification of 225AC from Irradiated 226RA-TARGETS
In force
 · High confidence
In forceHigh confidence
US 9,534,277Method for Purification of 225AC from Irradiated 226RA-TARGETS
In force
 · High confidence
In forceHigh confidence
US 8,153,087Method for the purification of radium from different sources
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,715,598Method for the purification of radium from different sources
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,603,954Methods for generating radioimmunoconjugates
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,736,975Infusion administration of conjugated monoclonal antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,241,512Stabilized Radio-Labeled ANTI-CD45 Immunoglobulin Compositions
In force
 · High confidence
In forceHigh confidence
US 10,420,851Stabilized Radiolabeled ANTI-CD45 Immunoglobulin Compositions
In force
 · High confidence
In forceHigh confidence
US 11,406,724Stabilized radiolabeled anti-CD45 immunoglobulin compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 32 patents shown.
Pro members see all 32.
Pro members: see all 32 patents
Also on record, not counted in the 32: 1 lapsed for an unpaid fee · 5 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

22 pending · 4 abandoned · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited